Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life-Reference-Cited by-同舟云学术

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

Published:2011-10 Issue:10 Volume:17 Page:1490-1496
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Alatrash Gheath,de Lima Marcos,Hamerschlak Nelson,Pelosini Matteo,Wang Xuemei,Xiao Lianchun,Kerbauy Fabio,Chiattone Alexandre,Rondon Gabriela,Qazilbash Muzaffar H.,Giralt Sergio A.,de Padua Silva Leandro,Hosing Chitra,Kebriaei Partow,Zhang Weiqing,Nieto Yago,Saliba Rima M.,Champlin Richard E.,Andersson Borje S.

Funder

NIH

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Acute myeloid leukaemia;Estey;Lancet,2006

2. Unrelated donor hematopoietic transplantation;de Lima;Rev Clin Exp Hematol,2001

3. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program;Kernan;N Engl J Med,1993

5. Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study;Fleming;Cancer Chemother Pharmacol,1995

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Patients;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial;Journal of Clinical Oncology;2023-10-10

3. Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients;Transplantation and Cellular Therapy;2023-08

4. Effects of combined test dose and therapeutic drug monitoring strategy in exposure-directed busulfan;Annals of Hematology;2023-04-13

5. Conditioning regimens for allogeneic hematopoietic cell transplantation in acute myeloid leukemia: Real-world data from the Japanese registry studies;Frontiers in Oncology;2022-11-25